Twenty-fifth annual general meeting of the British Association for Cancer Research. Abstracts of invited and profferred papers.
出版信息
Br J Cancer. 1984 Aug;50(2):239-78. doi: 10.1038/bjc.1984.170.
Abstract
摘要
相似文献
1
Twenty-fifth annual general meeting of the British Association for Cancer Research. Abstracts of invited and profferred papers.英国癌症研究协会第25届年度大会。特邀论文和投稿论文摘要。
Br J Cancer. 1984 Aug;50(2):239-78. doi: 10.1038/bjc.1984.170.
2
Twenty-sixth annual general meeting of the British Association for Cancer Research (in conjunction with the European Organization for Research and Treatment for Cancer--Pharmacokinetics and Metabolism Group and the Drug Metabolism Group). March 24-27, 1985, Birmingham, U.K.英国癌症研究协会第26届年会（与欧洲癌症研究与治疗组织——药代动力学与代谢小组及药物代谢小组联合举办）。1985年3月24日至27日，英国伯明翰
Br J Cancer. 1985 Sep;52(3):409-67. doi: 10.1038/bjc.1985.210.
3
British Association for Cancer Research 38th annual meeting. New Targets in Cancer Chemotherapy Southampton, United Kingdom, 1-4 April 1997. Abstracts.
Br J Cancer. 1997;75 Suppl 1(Suppl 1):1-53.
4
Preface. Combining clinical, translational and basic cancer drug research: the 2008 CESAR annual meeting.前言。结合临床、转化与基础癌症药物研究：2008年CESAR年会。
Int J Clin Pharmacol Ther. 2009 Jan;47(1):30-2. doi: 10.5414/cpp47030.
5
6
2017 ASCO Annual Meeting.
Lancet Oncol. 2017 Jul;18(7):853-854. doi: 10.1016/S1470-2045(17)30455-2. Epub 2017 Jun 8.
7
American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 2.
IDrugs. 2007 Aug;10(8):517-9.
8
9
10
American society of clinical oncology - 45th annual meeting. Part 1.美国临床肿瘤学会——第45届年会。第1部分。
IDrugs. 2009 Jul;12(7):401-3.
本文引用的文献
1
Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observations.通过铟-111 氧肟酸标记评估人类淋巴细胞转运：临床观察
Clin Exp Immunol. 1981 Mar;43(3):443-9.
2
The growth of human bladder and kidney cancers as xenografts in nude mice and rats.人类膀胱癌和肾癌在裸鼠和大鼠体内作为异种移植瘤的生长情况。
Urol Res. 1982;10(6):293-9. doi: 10.1007/BF00255876.
3
Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.亲电子药物增强洛莫司汀抗肿瘤作用的构效关系
Br J Cancer. 1982 Aug;46(2):249-59. doi: 10.1038/bjc.1982.190.
4
5
6
Inhibition of human natural cytotoxicity by macromolecular antiproteases.大分子抗蛋白酶对人类自然细胞毒性的抑制作用。
J Immunol. 1981 Apr;126(4):1569-74.
7
Chemical and biological properties of a growth factor from human-cultured osteosarcoma cells: resemblance with platelet-derived growth factor.人培养骨肉瘤细胞生长因子的化学和生物学特性：与血小板衍生生长因子的相似性
J Cell Physiol. 1980 Nov;105(2):235-46. doi: 10.1002/jcp.1041050207.
8
Trilostane in the treatment of advanced breast cancer.曲洛司坦治疗晚期乳腺癌
Cancer Chemother Pharmacol. 1983;10(3):158-60. doi: 10.1007/BF00255752.
9
Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.米索硝唑对洛莫司汀药代动力学的影响——小鼠化学增敏的主要机制
Br J Cancer. 1983 May;47(5):659-69. doi: 10.1038/bjc.1983.104.
10
Zotero 插件